BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33324095)

  • 1. Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer.
    Wu J; Luo D; Li S
    Breast Cancer (Dove Med Press); 2020; 12():267-277. PubMed ID: 33324095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Target and Mechanism of the Xihuang Pill Based on Network Pharmacology for Lung Squamous Cell Carcinoma.
    Tu H; Li J; Xu W; Wang Z; Wang L
    Altern Ther Health Med; 2023 Oct; 29(7):148-154. PubMed ID: 37442189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study on molecular mechanism of Xihuang pill in the treatment of glioblastoma based on network pharmacology and validation in vitro and in vivo.
    Xu HB; Chen XZ; Zhu SY; Xue F; Zhang YB
    J Ethnopharmacol; 2024 Apr; 323():117675. PubMed ID: 38159819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Regulation Mechanism of Xihuang Pill,
    Yang K; Zeng L; Ge A; Bao T; Xu T; Xie X; Liu L
    Front Pharmacol; 2020; 11():825. PubMed ID: 32595497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer.
    Zhuang Z; Huang D; Sheng ZR; Ye ZJ; Jiang H; Yuan Y; Qin B; Zhao Y; Pan HF; Tang Y
    Phytomedicine; 2023 Jan; 108():154491. PubMed ID: 36368285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on the Potential Molecular Mechanism of Xihuang Pill in the Treatment of Pancreatic Cancer Based on Network Pharmacology and Bioinformatics.
    Wang J; Zhang Y; Wang Q; Wang L; Zhang P
    Evid Based Complement Alternat Med; 2022; 2022():4651432. PubMed ID: 35449823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network Pharmacology-Based Strategy for Predicting Therapy Targets of Traditional Chinese Medicine Xihuang Pill on Liver Cancer.
    Zhao X; Hao J; Chen S
    Evid Based Complement Alternat Med; 2020; 2020():6076572. PubMed ID: 32256653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Based on Network Pharmacology to Explore the Molecular Targets and Mechanisms of Gegen Qinlian Decoction for the Treatment of Ulcerative Colitis.
    Wei M; Li H; Li Q; Qiao Y; Ma Q; Xie R; Wang R; Liu Y; Wei C; Li B; Zheng C; Sun B; Yu B
    Biomed Res Int; 2020; 2020():5217405. PubMed ID: 33299870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systems pharmacology in combination with proteomics reveals underlying mechanisms of Xihuang pill against triple-negative breast cancer.
    Xu X; Zhang J; Zhang Z; Wang M; Liu Y; Li X
    Bioengineered; 2020 Dec; 11(1):1170-1188. PubMed ID: 33092442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network pharmacology and molecular docking study on the mechanism of colorectal cancer treatment using Xiao-Chai-Hu-Tang.
    Jin J; Chen B; Zhan X; Zhou Z; Liu H; Dong Y
    PLoS One; 2021; 16(6):e0252508. PubMed ID: 34125845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Pharmacological Mechanisms of Xihuang Pills Against Prostate Cancer
    Wu Y; You X; Lin Q; Xiong W; Guo Y; Huang Z; Dai X; Chen Z; Mei S; Long Y; Tian X; Zhou Q
    Front Pharmacol; 2021; 12():791269. PubMed ID: 35342388
    [No Abstract]   [Full Text] [Related]  

  • 12. Network Pharmacology-Based Identification of Key Mechanisms of Xihuang Pill in the Treatment of Triple-Negative Breast Cancer Stem Cells.
    Zhang YZ; Yang JY; Wu RX; Fang C; Lu H; Li HC; Li DM; Zuo HL; Ren LP; Liu XY; Xu R; Wen JH; Huang HD; Hong R; Chen QJ
    Front Pharmacol; 2021; 12():714628. PubMed ID: 34737698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilising network pharmacology to explore the underlying mechanism of Wumei Pill in treating pancreatic neoplasms.
    Wan Y; Xu L; Liu Z; Yang M; Jiang X; Zhang Q; Huang J
    BMC Complement Altern Med; 2019 Jul; 19(1):158. PubMed ID: 31272505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.
    Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P
    J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Based on BATMAN-TCM to Explore the Molecular Mechanism of Xihuang Pill Regulating Immune Function to Treat Breast Precancerous Lesions.
    Li D; Fan H; Dong J; Sun C; Su Y; Liu J; Gu Y
    Breast Cancer (Dove Med Press); 2021; 13():725-742. PubMed ID: 34992452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xihuang pill induces pyroptosis and inhibits progression of breast cancer cells via activating the cAMP/PKA signalling pathway.
    Chen C; Yuan S; Chen X; Xie J; Wei Z
    Am J Cancer Res; 2023; 13(4):1347-1362. PubMed ID: 37168335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mechanism of Danggui Sini Decoction in treatment of primary dysmenorrhea based on network pharmacology and molecular docking].
    Que DH; Chen WH; Jiang FP; Pan F; Yang K
    Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):855-864. PubMed ID: 33645090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanisms of celastrol in treating papillary thyroid carcinoma based on network pharmacology and experiment verification.
    Yi J; Tian M; Hu L; Kang N; Ma W; Zhi J; Zheng X; Ruan X; Gao M
    Ann Transl Med; 2021 May; 9(10):866. PubMed ID: 34164500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xihuang pill promotes apoptosis of Treg cells in the tumor microenvironment in 4T1 mouse breast cancer by upregulating MEKK1/SEK1/JNK1/AP-1 pathway.
    Su L; Jiang Y; Xu Y; Li X; Gao W; Xu C; Zeng C; Song J; Weng W; Liang W
    Biomed Pharmacother; 2018 Jun; 102():1111-1119. PubMed ID: 29710529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.